2004
In January 2004, Reyataz® (atazanavir sulfate), was launched in Canada and approved in March for marketing in Europe.
Building on the success of the 2003 event, Armstrong and Bristol-Myers Squibb joined together once again to sponsor the 2004 Tour of Hope coast-to-coast cycling event.
